SELLAS Life Sciences Group, Inc. SLS Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $5.13M+60.0% | $4.73M+6.6% | $4.22M-3.3% | $3.87M-25.4% | $3.21M-37.3% | ||
| $4.12M+44.3% | —— | —— | —— | $2.86M— | ||
| $9.25M+52.6% | $8.26M+19.3% | $7.08M-3.4% | $6.87M-9.8% | $6.06M-37.1% | ||
| -$9.25M-52.6% | -$8.26M-19.3% | -$7.08M+3.4% | -$6.87M+9.8% | -$6.06M+37.1% | ||
| $845K+238% | $597K+230% | $292K+32.1% | $272K+80.1% | $250K+216% | ||
| -$8.41M-44.6% | -$7.66M-13.7% | -$6.79M+4.5% | -$6.6M+11.6% | -$5.81M+39.2% | ||
| -$0.05+28.6% | -$0.05+37.5% | -$0.06+40.0% | -$0.07+46.2% | -$0.07+66.7% | ||
| -$0.05+28.6% | -$0.05+37.5% | -$0.06+40.0% | -$0.07+46.2% | -$0.07+66.7% | ||
| 172.5M+96.5% | 109.1M+78.2% | 108.4M+58.8% | 98.6M+71.0% | 87.8M+95.8% | ||
| 172.5M+96.5% | 109.1M+78.2% | 108.4M+58.8% | 98.6M+71.0% | 87.8M+95.8% | ||
| $845K+238% | $597K+230% | $292K+32.1% | $272K+80.1% | $250K+216% | ||
| $685K+147% | —— | -$1.03M+41.7% | -$441K+58.4% | $277K-84.7% | ||
| -$1.26M+56.3% | —— | —— | -$488K+65.8% | -$2.9M-178% | ||
| $652K-42.4% | —— | $635K— | $291K+334% | $1.13M-53.6% | ||
| $44.15M+87.2% | $32.39M+404,825% | $26.09M+32.5% | $4.23M+922% | $23.58M-11.5% | ||
| -$8.85M+2.5% | -$4.92M+31.2% | -$7.07M+9.5% | -$7.33M+24.3% | -$9.07M+15.7% | ||
| $5.13M+60.0% | $4.73M+6.6% | $4.22M-3.3% | $3.87M-25.4% | $3.21M-37.3% | ||
| $798K+58.0% | $447K+19.8% | $503K+32.0% | $501K+50.0% | $505K+6.1% | ||
| -$9.25M-52.6% | -$8.26M-19.3% | -$7.08M+3.4% | -$6.87M+9.8% | -$6.06M+37.1% | ||
| —— | —— | —— | —— | —— | ||
| -$9.25M-52.6% | -$8.26M-19.3% | -$7.08M+3.4% | -$6.87M+9.8% | -$6.06M+37.1% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are SELLAS Life Sciences Group, Inc.'s profit margins?
- Gross margin is 90.0% and operating margin is -4195.0%, with a -4130.1% net margin.
- Where does SELLAS Life Sciences Group, Inc.'s income statement data come from?
- Every line is extracted from SELLAS Life Sciences Group, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.